Skip to main content
. Author manuscript; available in PMC: 2021 Jul 16.
Published in final edited form as: J Biomol Screen. 2012 Apr 24;17(7):957–965. doi: 10.1177/1087057112444927

Fig. 2. Potency determinations using an E. coli GUS enzyme assay.

Fig. 2

Concentration response data for compounds was normalized to controls with and without enzyme and plotted as percent activity. Potency determinations of nialamide (●), isocarboxazid (▲), phenelzine (□), amoxapine (■), loxapine (○) and mefloquine (♦) resulted in average IC50 values (nM) and SDs of 71 ± 32, 128 ± 56, 2,282 ± 1,041, 388 ± 98, >100,000 and 1,212 ± 234, respectively. The average Hill slope values derived from the IC50 curves of all active drugs ranged from 0.93 – 1.26. Data points represent the average of three determinations per concentration and error bars represent standard deviation. Data are representative of three independent experiments.